Transesophageal echocardiography before cardioversion of recurrent atrial fibrillation: Does absence of previous atrial thrombi preclude the need of a repeat test?

American Heart Journal

Volumn 146, Issue 4, 2003, Pages 741-745

  Shen, Xuedong ^a   Li, Huagui ^a   Rovang, Karen ^a   Hee, Tom ^a   Holmberg, Mark J ^a   Mooss, Aryan N ^a   Mohiuddin, Syed M ^a  

^a CREIGHTON UNIVERSITY CARDIAC CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ECHO CONTRAST MEDIUM; WARFARIN;

ADULT; AGED; ARTICLE; CARDIOVERSION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE DURATION; FEMALE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART DILATATION; HEART EJECTION FRACTION; HEART SIZE; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PATIENT; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VELOCITY;

EID: 0142120410     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00390-9     Document Type: Article

References (26)

1. Nattel S, Hadjis T, Talajic M. The treatment of atrial fibrillation: an evaluation of drug therapy, electrical modalities and therapeutic considerations. Drugs 1994;48:345-71.
2. Klein AL, Grimm RA, Murray RD, et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001;344:1411-20.
3. Klein AL, Grimm RA, Black IW, et al. Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot study. Ann Intern Med 1997;126:200-9.
4. Lown B, Perlroth MG, Kaidey S, et al. Cardioversion of atrial fibrillation: a report on the treatment of 65 episodes in 50 patients. N Engl J Med 1963;269:325-31.
5. Balslov JT, Holm I, Jorgensen HE, et al. Treatment of cardiac arrest in 200 patients with special reference to results and complication. Nord Med 1968;79:243-9.
6. Aberg H, Cullhed I. Direct current countershock complication. Acta Med 1968;183:415-21.
7. Lown B. Electrical reversion of cardiac arrhythmias. Br Heart J 1967;29:469-89.
8. Resnekov L, McDonald L. Complication in 220 patients with cardiac dysrhythmias treated by phased direct current shock, and indication for electroconversion. Br Heart J 1967;29:926-36.
9. Selzer A, Kelly JJ, Johnson RB, et al. Immediate and long term results of electrical cardioversion of arrhythmias. Prog Cardiovasc Dis 1966;9:90-104.
10. Bjerkelund CJ, Orning OM. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. Am J Cardiol 1969;23:208-16.
11. Henry WL, Morganroth J, Pearlman AS, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976;53:273-9.
12. Stein B, Halperin JL, Fuster V. Should patients with atrial fibrillation be anticoagulated prior to and chronically following cardioversion? Cardiovasc Clin 1990;21:231-47.
13. Laupacis A, Albers G, Dalen J, et al. Antithrombotic therapy in atrial fibrillation. Chest 1995;108:352S-9S.
14. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998;128:639-47.
15. Kamp O, Verhorst PMJ, Visser CA. Transesophageal echocardiography for early cardioversion of atrial fibrillation. Am J Cardiol 2000;86(Suppl):46G-50G.
16. Xuedong S, Huagui L, Karen R, et al. Prevalence of intraatrial thrombi in atrial fibrillation patients with sub-therapeutic international normalized ratios while on conventional anticoagulation. Am J Cardiol 2002;90:660-2.
17. Seidl K, Rameken M, Drogemuller A, et al. Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion: final results of the Ludwigshafen Observational Cardioversion Study. J Am Coll Cardiol 2002;39:1436-42.
18. Grimm RA, Stewart WJ, Maloney JD, et al. Impact of electrical cardioversion of atrial fibrillation on left atrial appendage function and smoker: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol 1993;22:1359-66.
19. Fatkin D, Kuchar DL, Thorburn CW, et al. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for 'atrial stunning' as a mechanism of thromboembolic complications. J Am Coll Cardiol 1994;23:307-16.
20. Laupacis A, Albers G, Dunn M, et al. Antithrombotic therapy in atrial fibrillation. Chest 1992;102:426S-33S.
21. Stoddard MF, Dawkings PR, Prince CR, et al. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol 1995;25:452-9.
22. Black IW, Fatkin D, Sagar KB, et al. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation: a multicenter study. Circulation 1994;89:2509-13.
23. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, II: echocardiographic features of patients at risk. Ann Intern Med 1992;116:6-12.
24. Blackshear JL, Pearce LA, Asinger RW, et al. Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation: Stroke Prevention in Atrial Fibrillation Investigators. Am J Cardiol 1993;72:840-3.
25. Rosenthal MS, Halperin JL. Thromboembolism in nonvalvular atrial fibrillation: the answer may be in the ventricle. Int J Cardiol 1992;37:277-82.
26. Anonymous. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: stroke prevention in atrial fibrillation II study: the SPSF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. JAMA 1998;279:1273-7.